PCI Biotech and Ultimovacs awarded NOK 500,000 from Innovation Norway

The grant will be used to further development of the existing preclinical research collaboration of the two companies.

CEO Jónas Einarsson in E24

*From the laboratory to rocket on the stock exchange – he turns medicine to gold.*

Vaccibody raised MNOK 220

The Private Placement was significantly oversubscribed by both existing shareholders and new investors.

PCI Biotech: Successful Investigational New Drug application

PCI Biotech has received clearance by the United States Food and Drug Administration (FDA) to include patients in the US.

Nordic Naonvector raised 497 MNOK

The Private Placement was oversubscribed and attracted strong interest from both existing shareholders and new institutional investors.

Nordicna Novector

Nordic Nanovector appoints Dr Lisa Rojkjaer, MD as Chief Medical Officer

Nordic Nanovector ASA (OSE: NANO) is pleased to announce that Lisa Rojkjaer, MD has joined the company today as Chief Medical Officer (CMO) and as a member of the Executive Management Team. Dr Rojkjaer will lead all clinical development strategy and execution and support the company’s efforts to identify opportunities to expand its pipeline of […]

Photocure ASA: Third Quarter 2016

Photocure delivers strong third quarter results.

Oncoimmunity, Vaccibody, Nextera and Nordic Nanovector granted BIA-funding

The Norwegian Research Council granted  Oslo Cancer Cluster member companies Oncoimmunity, Vaccibody, Nextera and Nordic Nanovector funding through the Programme for User-Driven Research Based Innovation (BIA). In total, the Norwegian Research Council will grant 532 MNOK to 50 Norwegian companies, of which 10 are within biomedicine. Oncoimmunity, Vaccibody, Nextera and Nordic Nanovector will receive between […]